Details for New Drug Application (NDA): 050550
✉ Email this page to a colleague
NDA 050550 describes MOXAM, which is a drug marketed by Lilly and is included in one NDA. Additional details are available on the MOXAM profile page.
The generic ingredient in MOXAM is moxalactam disodium. There is one drug master file entry for this compound. Additional details are available on the moxalactam disodium profile page.
The generic ingredient in MOXAM is moxalactam disodium. There is one drug master file entry for this compound. Additional details are available on the moxalactam disodium profile page.
Summary for 050550
| Tradename: | MOXAM |
| Applicant: | Lilly |
| Ingredient: | moxalactam disodium |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 050550
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 250MG BASE/VIAL | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 500MG BASE/VIAL | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 1GM BASE/VIAL | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
